stella
beta
Study Assessing Left Ventricular Administration of a Genetic Medicine Directing Organ Regeneration in Heart Failure — Stella
Recruiting
Back to Heart Failure With Reduced Ejection Fraction trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Texas Heart Institute, Houston, Texas
View full record on ClinicalTrials.gov